Psychological intervention and health outcomes among women treated for breast cancer: a review of stress pathways and biological mediators.
Breast cancer is a common cancer among American women. The diagnosis, treatment, and the challenges of survivorship all have potential to increase women's levels of distress to levels that might influence their adaptation and possibly the course of their disease. Psychological distress can influence tumor progression via many different pathways (e.g., genetic changes, immune surveillance, pro-angiogenic processes). Psychological intervention has been shown to facilitate psychological adaptation to breast cancer. But can psychological intervention influence cancer relevant biological outcomes among breast cancer survivors? We review the literature on how psychological intervention can influence cancer relevant biological outcomes among breast cancer patients. We limited the present review to randomized controlled trials reported in the past 6 years that tested the effects of psychological intervention on biological dependent variables among patients with non-metastatic breast cancer. There are data to suggest that psychological intervention can influence neuroendocrine (e.g., cortisol) and immune function indicators, especially lymphocyte proliferation and TH1 cytokine production. Future psychological intervention studies should also focus on more newly discovered stress-tumor pathways (e.g., neuroendocrine processes promoting tumor growth and metastasis) and follow larger cohorts of the more vulnerable patients over longer periods to evaluate the biobehavioral mechanisms and lasting effects of these interventions on health and quality of life.
McGregor
Bonnie A
BA
Public Health Sciences Division, Fred Hutchinson Cancer Research Center, USA.
Antoni
Michael H
MH
D000223:Adaptation, Psychological; D001943:Breast Neoplasms / Q000378:metabolism / Q000523:psychology* / Q000628:therapy*; D005260:Female; D006801:Humans; D011613:Psychotherapy / Q000379:methods*; D011788:Quality of Life; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data; D013315:Stress, Psychological / Q000209:etiology* / Q000503:physiopathology / Q000523:psychology*; D016896:Treatment Outcome
Psychosom Med. 2000 May-Jun;62(3):337-45
10845347
J Clin Oncol. 2000 Feb;18(3):574-83
10653872
Nutr Cancer. 2002;44(2):127-38
12734058
Nat Med. 2006 Aug;12(8):939-44
16862152
Cancer. 2007 Sep 1;110(5):1130-8
17647221
Psychosom Med. 1998 Jan-Feb;60(1):48-51
9492239
Health Psychol. 2001 Jan;20(1):47-63
11199066
Ann N Y Acad Sci. 1999 Nov 18;892:297-307
10842670
J Clin Oncol. 2005 Sep 1;23(25):6097-106
16135476
Psychol Bull. 2004 Jul;130(4):601-30
15250815
Am J Psychiatry. 2006 Oct;163(10):1791-7
17012691
Arch Otolaryngol Head Neck Surg. 1987 Nov;113(11):1207-13
3663348
Neoplasma. 1993;40(2):81-5
8350959
Immunol Rev. 1995 Jun;145:61-89
7590831
Ann Behav Med. 2002 Fall;24(4):336-44
12434945
Health Psychol. 2001 Jan;20(1):20-32
11199062
Nat Rev Cancer. 2006 Mar;6(3):240-8
16498446
Brain Behav Immun. 2007 Oct;21(7):953-61
17467230
Psychosom Med. 2008 Jun;70(5):575-84
18541907
Cancer. 2002 Aug 15;95(4):808-15
12209725
Oncogene. 2003 May 19;22(20):3070-5
12789282
Brain Behav Immun. 2003 Feb;17 Suppl 1:S106-8
12615194
Breast Cancer Res. 2007;9(4):R44
17640330
Br J Sports Med. 1998 Jun;32(2):111-20
9631216
Cell. 2002 Jan 25;108(2):171-82
11832208
J Natl Cancer Inst. 2003 Aug 20;95(16):1211-8
12928346
Blood. 2004 Jul 1;104(1):81-8
15016651
Psychosom Med. 2000 May-Jun;62(3):304-8
10845343
Ann Behav Med. 2007 Nov-Dec;34(3):225-39
18020933
J Natl Cancer Inst. 1998 Jan 7;90(1):30-6
9428780
Health Psychol. 2008 Jan;27(1S):S20-31
18248102
J Psychosom Res. 2004 Jan;56(1):1-8
14987957
Lancet. 1989 Oct 14;2(8668):888-91
2571815
Psychosom Med. 1992 Jul-Aug;54(4):489-517
1502290
Brain Behav Immun. 2007 Mar;21(3):251-8
17008048
Br J Haematol. 1997 Sep;98(3):569-77
9332309
Health Psychol. 2005 Sep;24(5):508-16
16162045
Brain Behav Immun. 2003 Feb;17 Suppl 1:S112-8
12615196
Arterioscler Thromb. 1991 Sep-Oct;11(5):1250-7
1911710
Cancer Res. 2000 Feb 15;60(4):867-72
10706096
Cancer. 1993 Jul 15;72(2):491-501
8319179
J Immunol. 1985 Aug;135(2 Suppl):755s-765s
2861231
Arch Gen Psychiatry. 1993 Sep;50(9):681-9
8357293
Clin Cancer Res. 1999 Jun;5(6):1289-97
10389911
J Immunother. 1997 May;20(3):165-77
9181454
J Clin Oncol. 2005 Dec 10;23(35):8923-5
16339754
Health Psychol. 1995 Mar;14(2):101-8
7789344
Clin Cancer Res. 2006 May 1;12(9):2759-66
16675568
Brain Behav Immun. 2001 Mar;15(1):7-24
11259077
Breast Cancer Res Treat. 1993;26(1):55-65
8400324
J Gerontol B Psychol Sci Soc Sci. 2005 Mar;60 Spec No 1:32-41
15863708
J Clin Oncol. 2008 Feb 20;26(6):971-82
18281672
Psychooncology. 2001 Nov-Dec;10(6):490-502
11747061
Cancer. 2006 Feb 15;106(4):751-8
16400678
N Engl J Med. 1998 Jan 15;338(3):171-9
9428819
J Clin Oncol. 2005 Oct 1;23(28):7105-13
16192594
J Clin Oncol. 2005 Nov 20;23(33):8296-304
16219926
Biol Psychol. 2006 Jun;72(3):291-304
16406268
Res Immunol. 1991 Jun-Aug;142(5-6):425-9
1754715
J Clin Oncol. 2005 Sep 1;23(25):6083-96
16135475
Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17312-5
15574496
Ann N Y Acad Sci. 2000;917:29-37
11268355
Psychoneuroendocrinology. 2007 Jun;32(5):470-9
17459596
J Natl Cancer Inst. 2000 Jun 21;92(12):994-1000
10861311
Stress. 2003 Sep;6(3):173-88
13129811
J Clin Oncol. 2004 Sep 1;22(17):3570-80
15337807
Br J Cancer. 1995 Jun;71(6):1292-6
7779726
J Consult Clin Psychol. 2006 Dec;74(6):1143-52
17154743
Psychosom Med. 2008 Nov;70(9):1044-9
18842742